Anna-Luise is an Investment Director and a member of the Healthcare sector team. She joined Bridgepoint in 2018.
She has worked on a number of transactions, including Pharmazell and Novasep (now Axplora), Nuvias, Schuberg Philis and HBC.
Prior to joining Bridgepoint, she worked as a management consultant at The Boston Consulting Group in Munich. Anna-Luise holds an MSc in Management from ESSEC Business School Paris and a BSc in Economics from University of Bonn.